Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu -Sam Fazeli, Bloomberg Intelligence, Director of Research: Healthcare, Defence, Industrials &amp; Auto, discusses the latest in the biotech sector. Eli Lilly &amp; Co. agreed to buy AtaiBeckley Inc. for as much as $3.8 billion, underscoring growing interest from large drugmakers in psychedelic medicine. Separately, Merck &amp; Co. won US regulatory approval of a pill called Lipfendra to reduce LDL cholesterol. -Matt Henriksson, Bloomberg Intelligence Senior Equity Analyst, discusses earnings from Abbott Laboratories. Abbott Laboratories raised its 2026 profit guidance after a stronger-than-expected second quarter driven by improved performance across most of its business lines. The company now expects adjusted earnings to fall between $5.45 to $5.60 a share this year, and shares rose 14% after the announcement. -Mandeep Singh, Global Head of Tech Research for Bloomberg Intelligence, discusses Taiwan Semiconductor Manufacturing Co. raising its spending and revenue projections for the year, reflecting confidence that growth in demand for chips and data centers will extend into 2027 and beyond. Separately, Uber Technologies Inc. has agreed to buy Delivery Hero SE in a deal that values the German food-delivery company at $14.8 billion and expands the US firm’s global operations. See omnystudio.com/listener for privacy information.

Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker 

Bloomberg Intelligence

I don't love the word retirement because I think it has negative baggage. I like the word financial independence. If you were to be financial independent, like how would you spend your time? I think that's a better way to think about the end of life stage versus quote unquote retirement. The thing about AI for business, it may not automatically fit the way your business works. At IBM, we've seen this firsthand, but by embedding AI across HR, IT and procurement processes,

we've reduced costs by millions, slash repetitive tasks and freed thousands of hours for strategic work. Now we're helping companies get smarter by putting AI where it actually pays off, deep in the work that moves the business. Let's create smarter business, IBM. Get the news you need in just 15 minutes. Start your day with Bloomberg Daybreak, the podcast with a global view on the stories that matter. I'm Nathan Hager. And I'm Karen Moscow. Join us each morning for curated stories on current events,

politics, business, and foreign relations. Plus one conversation on the day's biggest developments all in just 15 minutes. Subscribe to Bloomberg Daybreak for a precise, thoughtful take on the stories that matter. Listen to Bloomberg Daybreak each morning on Apple, Spotify, or anywhere you listen. Bloomberg Audio Studios. Podcasts, radio, news.

You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern. On Apple CarPlay and Android Auto with the Bloomberg Business App. Listen on demand wherever you get your podcasts or watch us live on YouTube. Let's talk about what's going on in the healthcare space and pharmaceuticals in particular. A big deal here by Eli Lilly. It's made a lot of acquisitions, Paul.

Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.